100139-54-6 | 4-(Diethylamino)benzohydrazide

Packsize	Purity	Availability	Price	Discounted Price
250mg	95%	in stock	$65.00	$45.00
1g	95%	in stock	$73.00	$51.00
5g	95%	in stock	$201.00	$141.00

Description

• Catalog Number: AA01202
• Chemical Name: 4-(Diethylamino)benzohydrazide
• CAS Number: 100139-54-6
• Molecular Formula: C11H17N3O
• Molecular Weight: 207.2722
• MDL Number: MFCD01310809
• SMILES: CCN(c1ccc(cc1)C(=O)NN)CC

Computed Properties

• Complexity: 196
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 15
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 4
• XLogP3: 1.4

Upstream Synthesis Route

4-(Diethylamino)benzohydrazide, a versatile compound commonly utilized in chemical synthesis, serves as a valuable reagent in various reactions due to its unique properties. This organic compound plays a critical role in the production of pharmaceuticals, agrochemicals, and other specialty chemicals. Additionally, it is widely employed in the development of dyes and pigments, as well as in the synthesis of organic compounds for research purposes. Its ability to undergo diverse chemical transformations makes it an indispensable tool in the field of organic chemistry.In chemical synthesis, 4-(Diethylamino)benzohydrazide functions as a key building block, enabling the formation of complex molecular structures through reactions such as acylation, alkylation, and condensation. Its presence can facilitate the creation of novel compounds with desired properties, making it a valuable asset in the design and production of advanced materials. Moreover, its reactivity and stability make it a preferred choice for chemists seeking efficient and reliable methods for synthesizing target molecules with precision and control.

Literature

• A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes.

  Journal of medicinal chemistry 20111124

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501